Tianjin Medical University Cancer Institute and Hospital

Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.

Phase 2, Not yet recruiting, 2026, 40 people, 2 Oct 2026, clinicaltrials.gov

FMT Plus SHR-1701 With Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Phase 2, Not yet recruiting, 2026, 60 people, 29 Sept 2026, clinicaltrials.gov

NCT07828756

Phase 2, Not yet recruiting, 2026, 147 people, 18 Sept 2026, clinicaltrials.gov

NCT07778732

Phase 2, Not yet recruiting, 2026, 32 people, 21 Aug 2026, clinicaltrials.gov

NCT07733830

Phase 2, Recruiting, 2026, 120 people, 29 Jul 2026, clinicaltrials.gov

NCT07721103

Phase 2, Not yet recruiting, 2026, 110 people, 22 Jul 2026, clinicaltrials.gov

NCT07712094

Phase 2, Not yet recruiting, 2026, 56 people, 17 Jul 2026, clinicaltrials.gov

NCT07691632

Phase 2, Not yet recruiting, 2026, 35 people, 9 Jul 2026, clinicaltrials.gov

NCT07584031

Phase 2, Not yet recruiting, 2026, 200 people, 13 May 2026, clinicaltrials.gov

NCT07570914

Phase 2, Not yet recruiting, 2026, 28 people, 6 May 2026, clinicaltrials.gov

NCT07531979

Phase 2, Not yet recruiting, 2026, 93 people, 15 Apr 2026, clinicaltrials.gov

NCT07510594

Phase 2, Not yet recruiting, 2026, 48 people, 3 Apr 2026, clinicaltrials.gov

NCT07441486

Phase 2, Not yet recruiting, 2026, 50 people, 2 Mar 2026, clinicaltrials.gov

NCT07365410

Phase 2, Not yet recruiting, 2026, 60 people, 26 Jan 2026, clinicaltrials.gov

NCT07254416

Phase 4, Not yet recruiting, 2025, 120 people, 28 Nov 2025, clinicaltrials.gov

NCT07246317

Phase 2, Not yet recruiting, 2025, 188 people, 24 Nov 2025, clinicaltrials.gov

NCT07172412

Phase 2, Not yet recruiting, 2025, 165 people, 15 Sept 2025, clinicaltrials.gov

NCT07168980

Collaborator, Phase 2/3, Recruiting, 2025, 87 people, 11 Sept 2025, clinicaltrials.gov

NCT07162506

Phase 2, Recruiting, 2025, 120 people, 9 Sept 2025, clinicaltrials.gov

NCT07083375

Collaborator, Phase 2, Not yet recruiting, 2025, 56 people, 24 Jul 2025, clinicaltrials.gov